A Noteworthy Change at the FDA in Recent Years Is

Multiple Choice

A noteworthy change at the FDA in recent years is its:

A) greater reluctance to approve drugs for use in life-threatening situations due to high toxicity of such drugs
B) regulation of the sale of fish and shellfish
C) increased inspection of foreign fruit shipments
D) allowing quicker approval for use of drugs that show promise in treating life-threatening diseases
E) dropping the quarantine requirements that apply to animals brought into the U.S.